PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical
News

Turbine boosts AI platform to deliver cancer treatments

€20m financing will focus on treatment pathways, new partnerships, and team expansion. Turbine, a company that has developed a cell simulation platform, has compl...
Continue Reading →
News

Infex begins study of pseudomonas aeruginosa candidate RESP-X

Phase 1 research will evaluate the tolerability and safety of therapy among healthy volunteers. Infex – a company focusing on anti-infectives specialist – has ann...
Continue Reading →
News

Genmab, AbbVie grab priority review for cancer bispecific antibody

Danish biotech Genmab announced this week that the FDA had accepted its Biologics License Application and granted Priority Review for its B-cell lymphoma b...
Continue Reading →
News

AstraZeneca to donate 10,000 doses of flu vaccine

AstraZeneca announced this week that it would be donating 10,000 doses of its nasal spray flu vaccine, following pricing disputes with the Swiss Federal Office for P...
Continue Reading →
News

Provention Bio wins approval for first-in-class diabetes drug

NJ-based Provention Bio has announced that the U.S. FDA has approved its intravenous diabetes drug — the first and only immunomodulatory treatment to ...
Continue Reading →
News

Sequana announces results from study of direct sodium removal

All ten patients involved in the research effectively and rapidly eliminated persistent congestion. Sequana, a company focusing on liver disease, heart failure, a...
Continue Reading →
News

Norfolk and Norwich University Hospitals establishes therapy for ovarian cancer patients

The procedure is carried out following the completion of surgery to remove all visible diseases. Over the past two years, Norfolk and Norwich University Hospitals...
Continue Reading →
News

Lindis biotech presents encouraging data from bladder cancer trial

Data revealed that 100% of patients achieved a complete remission with no recurrence. Lindis Biotech has announced positive data from all three dose groups from i...
Continue Reading →
News

Priothera reveals positive mocravimod data

The therapy is well-tolerated in allogeneic haematopoietic cell transplantation (HCT) patients. Priothera – a company focusing on the development of its S1P recep...
Continue Reading →
News

Stada and Xbrane gain EU approval for biosimilar Ximluci

The partnership combines Xbrane’s protein-expression system with Stada’s management teams. Xbrane and Stada have announced that the European Commission has grante...
Continue Reading →

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026